Alterity Therapeutics Health Care
Biotech Healthcare

$0.007 0.001 (16.67%)

High $0.01	Low $0.01	Trades 19	Turnover $1,131	Volume 188,484
30 June 2023 at 4:10pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code ATH	Name Alterity Therapeutics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 217,508,327	Shares Floated 172,821,241	Held by Insiders 8.268%	Held by Institutions 18.914%

Directors & Officers

Name & Education	Position
Dr. David A. Stamler M.D.	CEO & Director
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A.	CFO & Company Secretary
Dr. Rudolph Emile Tanzi Ph.D.	Chief Scientific Advisor and Member of Research & Development Advisory Board
Dr. Steven D. Targum M.D.	Chief Medical Advisor
Dr. Robert Cherny	Head of Research

ATH Historic Dividends

Date	Amount
We found no dividends on record for ATH.

End of Day Prices

Date	Close	Volume	Change
31-Jul	$0.55	69,863	+0.02 (2.83%)
30-Jul	$0.53	4,027	+0.02 (3.92%)
29-Jul	$0.51	164,413	-0.02 (3.77%)
28-Jul	$0.53	68,232	-0.03 (6.19%)
27-Jul	$0.57	14,025	+0.00 (0.89%)
24-Jul	$0.56	258,611	-0.01 (2.61%)
23-Jul	$0.58	61,936	+0.01 (1.77%)
22-Jul	$0.57	76,784	+0.01 (2.73%)
21-Jul	$0.55	28,306	0.00 (0.00%)
20-Jul	$0.55	688,512	-0.04 (6.78%)
17-Jul	$0.59	33,706	+0.58 (5,263.64%)
18-Sep	$0.01	8,521,381	0.00 (12.00%)
12-Sep	$0.01	1,963,777	+0.00 (4.17%)
11-Sep	$0.01	2,408,866	0.00 (7.69%)
05-Sep	$0.01	0	0.00 (0.00%)
7 up, 6 down, and 2 flat days

Market Cap (31-Jul) $121,804,656	EBITDA -	PE 10.33	Book Value $0.25
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.07	Profit Margin N/A
Operating Margin -372.59%	ROA 32.54%	ROE 47.03%	Revenue (FY) $6,636,421
Revenue per Share $0.04	Gross Profit (FY) $6,473,641	Q' YOY Revenue Growth 74.6%	Q' YOY Earnings Growth -

Alterity Therapeutics Health Care
Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

ATH Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Alterity Therapeutics Health Care Biotech Healthcare

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

ATH Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Alterity Therapeutics Health Care
Biotech Healthcare